Clinical Trial Update: Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating infusional fluorouracil plus weekly docetaxel in gastric cancer with bone marrow involvement and DIC; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Intravascular Coagulation
• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Gastric Cancer, Bone Marrow Metastasis | Phase 2 | Status: COMPLETED